Database Query Results : Auranofin, ,

Aur, Auranofin: Click to Expand ⟱
Features:
Auranofin is a synthetic gold(I) complex originally developed for the treatment of rheumatoid arthritis. Its structure features a gold atom coordinated with triethylphosphine and a thiolate ligand derived from a sugar (often referred to as a thiosugar).

Pathways:
1.Thioredoxin Reductase (TrxR) Inhibition.
- Most widely recognized for potently inhibiting TrxR.
2.Induction of Reactive Oxygen Species (ROS) and Oxidative Stress.
3.MMP depolarization, release of cytochrome c
4.Endoplasmic Reticulum (ER) Stress and Unfolded Protein Response (UPR)
5.Inhibition of Pro-survival Pathways (e.g., NF-κB Signaling)

-ic50 for cancer typically 1-3uM, normal cell 5-10uM or higher.
-Several studies animal testing antitumor efficacy have used doses in the region of 5–8 mg/kg via intraperitoneal injection or oral administration.

-Auranofin’s anticancer activity is often linked to its inhibition of thioredoxin reductase, leading to increased oxidative stress.
Scientific Papers found: Click to Expand⟱
1900- Aur,    Potential Anticancer Activity of Auranofin
- Review, Var, NA
"highlight2" >TrxR↓, "highlight2" >ROS↑, "highlight2" >Apoptosis↓, "highlight2" >TumCP↓, "highlight2" >eff↑,
2951- PL,  Aur,    Synergistic Dual Targeting of Thioredoxin and Glutathione Systems Irrespective of p53 in Glioblastoma Stem Cells
- in-vitro, GBM, U87MG
"highlight2" >GSH↓, "highlight2" >eff↑, "highlight2" >GSTP1/GSTπ↓,
1459- SFN,  Aur,    Auranofin Enhances Sulforaphane-Mediated Apoptosis in Hepatocellular Carcinoma Hep3B Cells through Inactivation of the PI3K/Akt Signaling Pathway
- in-vitro, Liver, Hep3B - in-vitro, Liver, HepG2
"highlight2" >eff↑, "highlight2" >TumCCA↑, "highlight2" >Apoptosis↑, "highlight2" >MMP↓, "highlight2" >BAX↑, "highlight2" >cl‑PARP↑, "highlight2" >Casp3↑, "highlight2" >Casp8↑, "highlight2" >Casp9↑, "highlight2" >ROS↑, "highlight2" >eff↓, "highlight2" >PI3K↓, "highlight2" >Akt↓, "highlight2" >TrxR↓, "highlight2" >BAX↑, "highlight2" >Bcl-2∅,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

GSH↓, 1,   GSTP1/GSTπ↓, 1,   ROS↑, 2,   TrxR↓, 2,  

Mitochondria & Bioenergetics ⓘ

MMP↓, 1,  

Cell Death ⓘ

Akt↓, 1,   Apoptosis↓, 1,   Apoptosis↑, 1,   BAX↑, 2,   Bcl-2∅, 1,   Casp3↑, 1,   Casp8↑, 1,   Casp9↑, 1,  

DNA Damage & Repair ⓘ

cl‑PARP↑, 1,  

Cell Cycle & Senescence ⓘ

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

PI3K↓, 1,  

Migration ⓘ

TumCP↓, 1,  

Drug Metabolism & Resistance ⓘ

eff↓, 1,   eff↑, 3,  
Total Targets: 19

Pathway results for Effect on Normal Cells:


Total Targets: 0

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:273  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page